Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study

DSpace Repository

Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study

Author: Layton, A. M.; Schaller, M.; Homey, B.; Hofmann, M. A.; Bewley, A. P.; Lehmann, P.; Nohlgard, C.; Sarwer, D. B.; Kerrouche, N.; Ma, Y. M.
Tübinger Autor(en):
Schaller, Martin
Published in: Journal of The European Academy of Dermatology and Venereology (2015), Bd. 29, H. 12, S. 2405-2410
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/jdv.13305
ISSN: 1468-3083
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)